Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nucleic Acids Res
2000 Mar 01;285:1154-61. doi: 10.1093/nar/28.5.1154.
Show Gene links
Show Anatomy links
Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes.
Bailey C
,
Weeks DL
.
???displayArticle.abstract???
Triplex-forming oligonucleotides (TFOs) modified with N,N-diethylethylenediamine can inhibit the expression of a reporter plasmid in Xenopus oocytes if the triplex is preformed prior to injection while unmodified oligonucleotides cannot. Here we show that merely forming a triplex in a reporter plasmid does not disrupt transcription, but when TFOs are targeted to sites within the transcribed region of a reporter gene then gene activity is inhibited. TFO-based inhibition did not lead to large scale degradation or mutation of the reporter plasmid, but dramatically lowered mRNA levels. Finally, we investigated the accessibility of a triplex target site on a reporter plasmid after injection into nuclei. We found that the site used for our previous studies was inaccessible to restriction endonuclease after injection into nuclei. This observation may explain why inhibition was dependent on forming the triplex before injection into oocytes. Based on the assumption that oligonucleotide association, like restriction enzyme access, was excluded by nucleosome formation, additional target sites were inserted so that all sites could not simultaneously be associated with the octamer core of a nucleosome. With multiple target sites prior association of the plasmid with nuclear proteins does not prevent oligonucleotide-mediated inhibition of gene activity.
Bailey,
Cationic oligonucleotides can mediate specific inhibition of gene expression in Xenopus oocytes.
1998, Pubmed,
Xenbase
Bailey,
Cationic oligonucleotides can mediate specific inhibition of gene expression in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Brown,
Nucleosome core particles inhibit DNA triple helix formation.
1996,
Pubmed
Chomczynski,
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
1987,
Pubmed
Dagle,
Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation.
1996,
Pubmed
Dagle,
Pathways of degradation and mechanism of action of antisense oligonucleotides in Xenopus laevis embryos.
1991,
Pubmed
,
Xenbase
Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase
Durland,
Binding of T and T analogs to CG base pairs in antiparallel triplexes.
1994,
Pubmed
Ebbinghaus,
Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex-directed covalent modification of the template strand.
1999,
Pubmed
Escudé,
Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.
1996,
Pubmed
Fragoso,
The position and length of the steroid-dependent hypersensitive region in the mouse mammary tumor virus long terminal repeat are invariant despite multiple nucleosome B frames.
1998,
Pubmed
Froehler,
Synthesis of DNA via deoxynucleoside H-phosphonate intermediates.
1986,
Pubmed
Gargiulo,
Analysis of the chromatin assembled in germinal vesicles of Xenopus oocytes.
1983,
Pubmed
,
Xenbase
Gargiulo,
Chromatin-specific hypersensitive sites are assembled on a Xenopus histone gene injected into Xenopus oocytes.
1985,
Pubmed
,
Xenbase
Jones,
Regulation of adenovirus transcription by an E1a gene in microinjected Xenopus laevis oocytes.
1983,
Pubmed
,
Xenbase
Kim,
Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
1995,
Pubmed
Kim,
Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
1998,
Pubmed
Kim,
A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
1998,
Pubmed
Kovacs,
Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription.
1996,
Pubmed
Kroll,
Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation.
1996,
Pubmed
,
Xenbase
Maher,
Inhibition of T7 RNA polymerase initiation by triple-helical DNA complexes: a model for artificial gene repression.
1992,
Pubmed
Minshull,
Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis.
1989,
Pubmed
,
Xenbase
Mymryk,
Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.
1995,
Pubmed
Svinarchuk,
Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor.
1996,
Pubmed
Svinarchuk,
A new approach to overcome potassium-mediated inhibition of triplex formation.
1996,
Pubmed
Vasquez,
Triplex-directed modification of genes and gene activity.
1998,
Pubmed
Wang,
Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation.
1995,
Pubmed
Wang,
Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair.
1996,
Pubmed
Wang,
DNA damage-dependent transcriptional arrest and termination of RNA polymerase II elongation complexes in DNA template containing HIV-1 promoter.
1997,
Pubmed
Weeks,
Cyclin B mRNA depletion only transiently inhibits the Xenopus embryonic cell cycle.
1991,
Pubmed
,
Xenbase
Westin,
Triple helix DNA alters nucleosomal histone-DNA interactions and acts as a nucleosome barrier.
1995,
Pubmed
Xodo,
Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
1994,
Pubmed
